Literature DB >> 21984806

TACI deficiency impairs sustained Blimp-1 expression in B cells decreasing long-lived plasma cells in the bone marrow.

Shoichiro Tsuji1, Catarina Cortesão, Richard J Bram, Jeffrey L Platt, Marilia Cascalho.   

Abstract

Deficiencies in transmembrane activator and CAML interactor (TACI) result in common variable immune deficiency, a syndrome marked by recurrent infections with encapsulated microorganisms, impaired production of antibodies, and lymphoproliferation. How TACI promotes antibody production and inhibits lymphoproliferation is not understood. To answer this question, we studied the generation of immunity to protein antigens in both TACI-deficient and TACI-proficient mice. We show that TACI promotes sustained Blimp-1 expression by B cells responding to antigen, which in turn limits B-cell clonal expansion and facilitates differentiation of long-lived antibody-secreting cells. Short-term IgG secretion occurs independently of TACI as DNA double-strand breaks associated with isotype class switching induce Blimp-1 transiently, independently of TACI. Our results showing that TACI induces and maintains Blimp-1 provide, for the first time, a unified molecular and cellular mechanism explaining the primary features of common variable immune deficiency, exquisite vulnerability to infection with encapsulated organisms, lymphoproliferation, and hypogammaglobulinemia.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21984806      PMCID: PMC3228499          DOI: 10.1182/blood-2011-05-353961

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  32 in total

1.  TACI is required for efficient plasma cell differentiation in response to T-independent type 2 antigens.

Authors:  George T Mantchev; Catarina S Cortesão; Michelle Rebrovich; Marilia Cascalho; Richard J Bram
Journal:  J Immunol       Date:  2007-08-15       Impact factor: 5.422

2.  Mismatch repair co-opted by hypermutation.

Authors:  M Cascalho; J Wong; C Steinberg; M Wabl
Journal:  Science       Date:  1998-02-20       Impact factor: 47.728

3.  DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139.

Authors:  E P Rogakou; D R Pilch; A H Orr; V S Ivanova; W M Bonner
Journal:  J Biol Chem       Date:  1998-03-06       Impact factor: 5.157

4.  Mutations in TNFRSF13B encoding TACI are associated with common variable immunodeficiency in humans.

Authors:  U Salzer; H M Chapel; A D B Webster; Q Pan-Hammarström; A Schmitt-Graeff; M Schlesier; H H Peter; J K Rockstroh; P Schneider; A A Schäffer; L Hammarström; B Grimbacher
Journal:  Nat Genet       Date:  2005-07-10       Impact factor: 38.330

5.  TACI is mutant in common variable immunodeficiency and IgA deficiency.

Authors:  Emanuela Castigli; Stephen A Wilson; Lilit Garibyan; Rima Rachid; Francisco Bonilla; Lynda Schneider; Raif S Geha
Journal:  Nat Genet       Date:  2005-07-10       Impact factor: 38.330

6.  TACI attenuates antibody production costimulated by BAFF-R and CD40.

Authors:  Daisuke Sakurai; Yumiko Kanno; Hidenori Hase; Hidefumi Kojima; Ko Okumura; Tetsuji Kobata
Journal:  Eur J Immunol       Date:  2007-01       Impact factor: 5.532

7.  Transmembrane activator and calcium modulator and cyclophilin ligand interactor enhances CD40-driven plasma cell differentiation.

Authors:  Emanuela Castigli; Stephen A Wilson; Abdallah Elkhal; Esra Ozcan; Lilit Garibyan; Raif S Geha
Journal:  J Allergy Clin Immunol       Date:  2007-08-08       Impact factor: 10.793

8.  Initiation of plasma-cell differentiation is independent of the transcription factor Blimp-1.

Authors:  Axel Kallies; Jhagvaral Hasbold; Kirsten Fairfax; Clare Pridans; Dianne Emslie; Brent S McKenzie; Andrew M Lew; Lynn M Corcoran; Philip D Hodgkin; David M Tarlinton; Stephen L Nutt
Journal:  Immunity       Date:  2007-05       Impact factor: 31.745

9.  Blimp-1 is required for maintenance of long-lived plasma cells in the bone marrow.

Authors:  Miriam Shapiro-Shelef; Kuo-I Lin; David Savitsky; Jerry Liao; Kathryn Calame
Journal:  J Exp Med       Date:  2005-11-28       Impact factor: 14.307

10.  TACI and BAFF-R mediate isotype switching in B cells.

Authors:  Emanuela Castigli; Stephen A Wilson; Sumi Scott; Fatma Dedeoglu; Shengli Xu; Kong-Peng Lam; Richard J Bram; Haifa Jabara; Raif S Geha
Journal:  J Exp Med       Date:  2005-01-03       Impact factor: 14.307

View more
  37 in total

1.  TACI deficiency leads to alternatively activated macrophage phenotype and susceptibility to Leishmania infection.

Authors:  Windy R Allman; Ranadhir Dey; Lunhua Liu; Shafiuddin Siddiqui; Adam S Coleman; Parna Bhattacharya; Masahide Yano; Kadriye Uslu; Kazuyo Takeda; Hira L Nakhasi; Mustafa Akkoyunlu
Journal:  Proc Natl Acad Sci U S A       Date:  2015-07-13       Impact factor: 11.205

2.  Circulating B cells in type 1 diabetics exhibit fewer maturation-associated phenotypes.

Authors:  Patrick Hanley; Jennifer A Sutter; Noah G Goodman; Yangzhu Du; Debora R Sekiguchi; Wenzhao Meng; Michael R Rickels; Ali Naji; Eline T Luning Prak
Journal:  Clin Immunol       Date:  2017-09-23       Impact factor: 3.969

3.  Differential induction of plasma cells by isoforms of human TACI.

Authors:  Yolanda Garcia-Carmona; Montserrat Cols; Adrian T Ting; Lin Radigan; Frank J Yuk; Li Zhang; Andrea Cerutti; Charlotte Cunningham-Rundles
Journal:  Blood       Date:  2015-01-28       Impact factor: 22.113

Review 4.  BAFF inhibition in SLE-Is tolerance restored?

Authors:  Shaun W Jackson; Anne Davidson
Journal:  Immunol Rev       Date:  2019-09-28       Impact factor: 12.988

5.  TNF receptor superfamily member 13b (TNFRSF13B) hemizygosity reveals transmembrane activator and CAML interactor haploinsufficiency at later stages of B-cell development.

Authors:  Neil Romberg; Manmeet Virdee; Nicolas Chamberlain; Tyler Oe; Jean-Nicolas Schickel; Tiffany Perkins; Tineke Cantaert; Rima Rachid; Sally Rosengren; Regina Palazzo; Raif Geha; Charlotte Cunningham-Rundles; Eric Meffre
Journal:  J Allergy Clin Immunol       Date:  2015-06-19       Impact factor: 10.793

6.  TACI deficiency enhances antibody avidity and clearance of an intestinal pathogen.

Authors:  Shoichiro Tsuji; Lucas Stein; Nobuhiko Kamada; Gabriel Nuñez; Richard Bram; Bruce A Vallance; Ana E Sousa; Jeffrey L Platt; Marilia Cascalho
Journal:  J Clin Invest       Date:  2014-10-01       Impact factor: 14.808

7.  Reduced BAFF-R and increased TACI expression in common variable immunodeficiency.

Authors:  Rita R Barbosa; Susana L Silva; Sara P Silva; Alcinda C Melo; M Conceição Pereira-Santos; João T Barata; Lennart Hammarström; Marília Cascalho; Ana E Sousa
Journal:  J Clin Immunol       Date:  2014-05-09       Impact factor: 8.317

8.  Increased expression of TACI on NOD B cells results in germinal centre reaction anomalies, enhanced plasma cell differentiation and immunoglobulin production.

Authors:  Viqar S Banday; Radha Thyagarajan; Mia Sundström; Kristina Lejon
Journal:  Immunology       Date:  2016-08-23       Impact factor: 7.397

9.  Development of systemic lupus erythematosus in NZM 2328 mice in the absence of any single BAFF receptor.

Authors:  Chaim O Jacob; Ning Yu; Shunhua Guo; Noam Jacob; William J Quinn; Vishal Sindhava; Michael P Cancro; Beatrice Goilav; Chaim Putterman; Thi-Sau Migone; William Stohl
Journal:  Arthritis Rheum       Date:  2013-04

Review 10.  B Cell-Activating Factor (BAFF)-Targeted B Cell Therapies in Inflammatory Bowel Diseases.

Authors:  Mathieu Uzzan; Jean-Frederic Colombel; Andrea Cerutti; Xavier Treton; Saurabh Mehandru
Journal:  Dig Dis Sci       Date:  2016-09-21       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.